Mithra Pharmaceuticals S.A. Logo

Mithra Pharmaceuticals S.A.

Biotech firm developing pharma for women's health: contraception, fertility, and menopause.

MITRA | BR

Overview

Corporate Details

ISIN(s):
BE0974283153 (+1 more)
LEI:
5493002FDD273HTEKK14
Country:
Belgium
Address:
Rue Saint-Georges 5, 4000 Liège
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mithra Pharmaceuticals S.A. is a biotechnology company dedicated to women's health. The company specializes in the development, manufacturing, and commercialization of proprietary and over-the-counter pharmaceutical products. Its core focus areas include contraception, fertility, and menopause. Mithra's mission is to transform the women's health sector by providing innovative new choices that aim to improve the overall quality of life for women.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-06-11 10:00
M&A Activity
2024-06-11_Mithra_Press-Release_Mithra sells to GR_EN-FS (003) (002)-PDF.pdf
English 179.8 KB
2024-06-11 10:00
M&A Activity
2024-06-11_Mithra_Press-Release_Mithra sells to GR_FR-FS-PDF.pdf
French 126.7 KB
2024-06-10 19:15
Legal Proceedings Report
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_EN.…
English 181.9 KB
2024-06-10 19:15
Legal Proceedings Report
2024-06-10_Mithra_Press-Release_Mithra files for bankruptcy AND sells to GR_FR.…
French 128.7 KB
2024-06-04 08:00
Legal Proceedings Report
2024-0~1.PDF
English 153.0 KB
2024-06-04 08:00
Legal Proceedings Report
2024-0~2.PDF
French 158.7 KB
2024-05-28 15:00
Pre-Annual General Meeting Information
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_EN.…
English 139.6 KB
2024-05-28 15:00
Pre-Annual General Meeting Information
2024-05-28_Mithra_Press-release_Mithra postpones its annual general meeting_FR.…
French 143.3 KB
2024-05-10 16:30
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_EN.pdf
English 124.3 KB
2024-05-10 16:30
Regulatory News Service
2024-05-10_Mithra_Press-release_Additional patent protection NEXSTELLIS_FR.pdf
French 126.5 KB
2024-05-03 17:30
M&A Activity
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
English 142.7 KB
2024-05-03 17:30
Capital/Financing Update
2024-05-03_Mithra_Press-release_Mithra Announces Exclusive Negotiations and Fun…
French 145.9 KB
2024-04-30 10:30
Proxy Solicitation & Information Statement
2024-04-30_MITHRA_VOTING-BY-MAIL-FORM_AGO-MAY-2024_EN.pdf
English 141.0 KB
2024-04-30 10:30
Pre-Annual General Meeting Information
2024-04-30_MITHRA_AGENDA_AGO-MAY-2024_FR.pdf
French 143.1 KB
2024-04-30 10:30
Proxy Solicitation & Information Statement
2024-04-30_MITHRA_PROXY-FORM_AGO-MAY-2024_EN.pdf
English 145.2 KB

Automate Your Workflow. Get a real-time feed of all Mithra Pharmaceuticals S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mithra Pharmaceuticals S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-01-17 NOSHAQ SA Board Other 172,574 617,814.92 EUR
2022-11-17 NOSHAQ SA Board Other 172,574 1,052,701.40 EUR
2022-07-18 NOSHAQ SA Board Other 156,250 1,006,250.00 EUR
2022-05-13 NOSHAQ SA Board Other 156,250 1,239,062.50 EUR
2022-04-13 Gordenne Valérie Other Sell 8,500 87,380.00 EUR
2022-03-29 Fornieri Francesco Board Sell 100,000 1,312,000.00 EUR
2022-03-25 Fornieri Francesco Board Sell 35,893 486,530.57 EUR
2022-03-24 Fornieri Francesco Board Sell 15,657 219,536.19 EUR
2022-03-24 Fornieri Francesco Board Sell 2,818 39,452.00 EUR
2022-03-23 Fornieri Francesco Board Sell 12,525 178,230.75 EUR

Peer Companies

Company Country Ticker View
Cellromax Science Co., Ltd. Logo
Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.
South Korea 471820
CellSeed Inc. Logo
Develops cell sheet products, culture equipment, and offers contract manufacturing services.
Japan 7776
CellSource Co.,Ltd. Logo
Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.
Japan 4880
Celltrion, Inc. Logo
A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.
South Korea 068270
Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland CLN
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea 083790
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea 261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea 052670
Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary RICHT

Talk to a Data Expert

Have a question? We'll get back to you promptly.